Menu Back toWelcome to Day 2 and Session 6: Keynote Address - Delivery of Oligonucleotide Therapeutics – Going Beyond the Liver

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Welcome to Day 2 and Session 6: Keynote Address - Delivery of Oligonucleotide Therapeutics – Going Beyond the Liver

Session Chair(s)

Andrew Adams, PhD, MBA

Andrew Adams, PhD, MBA

  • Vice President, Genetic Medicine
  • Eli Lilly and Company, United States
Discussion of the challenges and opportunities of next generation delivery approaches for RNA and DNA based medicines. Approaches spanning direct conjugation of ligands, antibody/peptide conjugates, blood brain barrier shuttles and nanoparticles will be covered, as well as potential therapeutic applications.

Contact us

Registration Questions?

Send Email
1.888.257.6457

Additional Information

Live Meeting Policies

Discover DIA’s Live In-Person and Live Virtual Events